Joon Lee Analyst PerformanceAnalyst at Truist FinancialJoon Lee is a stock analyst at Truist Financial, covering 19 publicly traded companies across a range of sectors. Over the past year, Joon Lee has issued 18 stock ratings, including buy and hold recommendations. While full access to Joon Lee's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Joon Lee's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings29 Last 5 YearsBuy Recommendations92.31% 24 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution26RatingsDistribution of strong buy, buy, hold, and sell ratings by Joon Lee.RatingPercentageCount Strong Buy0.0%0 ratings Buy92.3%24 ratings Hold7.7%2 ratings Sell0.0%0 ratingsOut of 26 total stock ratings issued by Joon Lee at Truist Financial, the majority (92.3%) have been Buy recommendations, followed by 7.7% Hold.Best & Worst CallsBest Call0000.0%CPRXMar 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%EDITAug 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ19 companiesJoon Lee, an analyst at Truist Financial, currently covers 19 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical19 companies100.0%Joon Lee of Truist Financial specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE14 companies73.7%MED - DRUGS4 companies21.1%PHARMACEUTICAL PREPARATIONS1 company5.3% Joon Lee's Ratings History at Truist Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsVRTXVertex Pharmaceuticals8/5/2025Set Price Target$392.94$490.00Buy$0.0000.00% ROIPTCTPTC Therapeutics7/29/2025Boost Price Target$49.79$86.00Buy$0.0000.00% ROIPTCTPTC Therapeutics6/17/2025Initiated Coverage$51.87$80.00Buy$0.0000.00% ROISAGESage Therapeutics6/17/2025Set Price Target$9.07$9.00Hold$0.0000.00% ROICORTCorcept Therapeutics5/6/2025Set Price Target$70.46$135.00$0.0000.00% ROIVKTXViking Therapeutics4/28/2025Reiterated Rating$25.54$75.00Buy$0.0000.00% ROIARVNArvinas4/9/2025Lower Price Target$6.19$21.00Buy$0.0000.00% ROICORTCorcept Therapeutics3/31/2025Boost Price Target$102.71$150.00Buy$0.0000.00% ROINTLAIntellia Therapeutics3/4/2025Lower Price Target$8.98$50.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines3/3/2025Lower Price Target$37.71$85.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics2/19/2025Boost Price Target$125.57$200.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics2/12/2025Boost Price Target$42.39$120.00Buy$0.0000.00% ROIVRTXVertex Pharmaceuticals2/11/2025Boost Price Target$460.13$520.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics2/3/2025Boost Price Target$106.86$190.00Buy$0.0000.00% ROILRMRLarimar Therapeutics1/29/2025Initiated Coverage$3.48$18.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines1/21/2025Boost Price Target$74.33$175.00Buy$0.0000.00% ROIARGXargenex1/14/2025Reiterated Rating$673.54$700.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics1/13/2025Boost Price Target$80.05$180.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
